Europe Epinephrine Market to Grow at a CAGR of 8.0% to reach US$ 1,238.80 million from 2019 to 2027

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Epinephrine Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Epinephrine Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Number of Anaphylaxis Cases

5.2 Market Opportunities

5.2.1 Growing Pipeline of Epinephrine

5.3 Future Trends

5.3.1 Introduction of generic version of epinephrine

5.4 Impact of Drivers and Restraints

6. Europe Epinephrine Market Regional Analysis

6.1 Europe Epinephrine Market Overview

6.2 Europe Epinephrine Market Revenue 2017-2027 (US$ Million)

6.3 Europe Epinephrine Market Forecast Analysis

7. Europe Epinephrine Market Analysis – by Product Type

7.1 Prefilled Syringes

7.1.1 Overview
7.1.2 Prefilled Syringes: Europe Epinephrine Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Auto-Injectors

7.2.1 Overview
7.2.2 Auto-Injectors: Europe Epinephrine Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Ampoules and Vials

7.3.1 Overview
7.3.2 Ampoules and Vials: Europe Epinephrine Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Epinephrine Market Analysis – by Application

8.1 Anaphylaxis

8.1.1 Overview
8.1.2 Anaphylaxis: Europe Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Superficial Bleeding

8.2.1 Overview
8.2.2 Superficial Bleeding: Europe Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)

8.3 Respiratory Disorders

8.3.1 Overview
8.3.2 Respiratory Disorders: Europe Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Cardiac Arrest

8.4.1 Overview
8.4.2 Cardiac Arrest: Europe Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)

9. Europe Epinephrine Market Analysis – by Distribution Channel

9.1 Retail Pharmacies

9.1.1 Overview
9.1.2 Cardiac Arrest: Europe Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)

9.2 Hospital Pharmacies

9.2.1 Overview
9.2.2 Cardiac Arrest: Europe Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)

9.3 Online Pharmacies

9.3.1 Overview
9.3.2 Cardiac Arrest: Europe Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)

10. Europe Epinephrine Market – Europe Analysis

10.1 Europe

10.1.1 Europe Epinephrine Market Breakdown, by Key Country, 2020 and 2027 (%)
10.1.1.1 Europe Epinephrine Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 UK: Europe Epinephrine Market Breakdown, by Product Type
10.1.1.1.2 UK: Europe Epinephrine Market Breakdown, by Application
10.1.1.1.3 UK: Europe Epinephrine Market Breakdown, by Distribution Channel

10.1.1.2 Germany: Europe Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 Germany: Europe Epinephrine Market Breakdown, by Product Type
10.1.1.2.2 Germany: Europe Epinephrine Market Breakdown, by Application
10.1.1.2.3 Germany: Europe Epinephrine Market Breakdown, by Distribution Channel

10.1.1.3 France: Europe Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 France: Europe Epinephrine Market Breakdown, by Product Type
10.1.1.3.2 France: Europe Epinephrine Market Breakdown, by Application
10.1.1.3.3 France: Europe Epinephrine Market Breakdown, by Distribution Channel

10.1.1.4 Russia: Europe Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.4.1 Russia: Europe Epinephrine Market Breakdown, by Product Type
10.1.1.4.2 Russia: Europe Epinephrine Market Breakdown, by Application
10.1.1.4.3 Russia: Europe Epinephrine Market Breakdown, by Distribution Channel

10.1.1.5 Italy: Europe Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.5.1 Italy: Europe Epinephrine Market Breakdown, by Product Type
10.1.1.5.2 Italy: Europe Epinephrine Market Breakdown, by Application
10.1.1.5.3 Italy: Europe Epinephrine Market Breakdown, by Distribution Channel

10.1.1.6 Rest of Europe: Europe Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Epinephrine Market Breakdown, by Product Type
10.1.1.6.2 Rest of Europe: Europe Epinephrine Market Breakdown, by Application
10.1.1.6.3 Rest of Europe: Europe Epinephrine Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Epinephrine Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Novartis AG

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Teva Pharmaceuticals Ltd.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Mylan N.V.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Amneal Pharmaceuticals LLC

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 ALK-Abelló A/S

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Abbott

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Kaleo, Inc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 BIOPROJET

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Medeca Pharma AB

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Erythpharm

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights